Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - November 2007

  1. Cost of Varicella-Related Hospitalisations in an Italian Paediatric Hospital: Comparison With Possible Vaccination Expenses.   Curr Med Res Opin; October 12, 2007. [Epub ahead of print].

  2. Recommended Adult Immunization Schedule: United States, October 2007 September 2008.   Ann Intern Med; October 18, 2007. [Epub ahead of print].

  3. Alfonso, H. C.; Gomez, O. C.; Fonte, L. M.; Quintana, Q. P.  [Isolation of a Strain From the Bataviae Pathogenic Complex in Patient Vaccinated Against Copenhageni, Canicola and Mozdok].   Rev Cubana Med Trop; 57 (1): 73-74; January, 2005.

  4. Arya, S. C.; Agarwal, N.  Baffling Measles Immunization Schedules for Young Infants.   Vaccine; September 21, 2007. [Epub ahead of print].

  5. Barreto, L.; Guasparini, R.; Meekison, W.; Noya, F.; Young, L.; Mills, E.  Humoral Immunity 5 Years After Booster Immunization With an Adolescent and Adult Formulation Combined Tetanus, Diphtheria, and 5-Component Acellular Pertussis Vaccine.   Vaccine; October 2, 2007. [Epub ahead of print].

  6. Billings, L.; Fiorillo, A.; Schwartz, I. B.   Vaccinations in Disease Models With Antibody-Dependent Enhancement.   Math Biosci; September 4, 2007. [Epub ahead of print].

  7. Borlaug, G.; Newman, A.; Pfister, J.; Davis, J. P.  Factors That Influenced Rates of Influenza Vaccination Among Employees of Wisconsin Acute Care Hospitals and Nursing Homes During the 2005-2006 Influenza Season.   Infect Control Hosp Epidemiol; 28 (12); October, 2007.

  8. Breban, R.; Vardavas, R.; Blower, S.  Mean-Field Analysis of an Inductive Reasoning Game: Application to Influenza Vaccination.   Phys Rev E Stat Nonlin Soft Matter Phys; 76 (3 Pt 1): 031127; September, 2007.

  9. Buelow, V. H.; Van, Hook J.  Timely Immunization Series Completion Among Children of Immigrants.   J Immigr Minor Health; October, 2007. [Epub ahead of print].

  10. Buttery, J. P.  Routine Rotavirus Vaccinations of Infants Cost US$138 Per Case Averted and US$197,190 Per Life Year Saved From a Societal Perspective.   Evid Based Med; 12 (5): 153; October, 2007.

  11. Campos-Outcalt, D.  Flu Vaccination Rates: How Can You Do Better?   J Fam Pract; 56 (10): 825-6, 828; October, 2007.

  12. Campos, M. A.; Alazemi, S.; Zhang, G.; Sandhaus, R. A.; Wanner, A.  Influenza Vaccination in Subjects With Alpha-1 Antitrypsin Deficiency.   Chest; October 1, 2007. [Epub ahead of print].

  13. Castel, A. D.; Reed, G.; Davenport, M. G.; Harrison, L. H.; Blythe, D.  College and University Compliance With a Required Meningococcal Vaccination Law.   J Am Coll Health; 56 (2): 119-127; September, 2007.

  14. Chumakov, K.; Ehrenfeld, E.; Wimmer, E.; Agol, V. I.  Vaccination Against Polio Should Not Be Stopped.   Nat Rev Microbiol; October 29, 2007. [Epub ahead of print].

  15. Covell, J. L.; Stoler, M. H.  Human Papillomavirus Testing, Vaccination, and Gynecologic Screening: Fight or Flight?   Am J Clin Pathol; 128 (5): 726-728; November, 2007.

  16. Danaher, P. J.; Cruz, W. P.; Thornton, J. A.; Savona, M. R.  Comparison of a Semipermeable Dressing Bonded to an Absorbent Pad and a Semipermeable Dressing Over a Separate Gauze Pad for Containment of Vaccinia Virus at the Vaccination Site.   Infect Control Hosp Epidemiol; 28 (12); October, 2007.

  17. de Jong, J. C.  [Influenza Vaccination in Health-Care Workers: an Effective Method to Reduce the Consequences of Influenza in Health Care Users].   Ned Tijdschr Geneeskd; 151 (39): 2143-2146; September 29, 2007.

  18. de Jong, J. C.  [New Target Populations for Influenza Vaccination; Recommendations of the Health Council of the Netherlands].   Ned Tijdschr Geneeskd; 151 (39): 2140-2142; September 29, 2007.

  19. Dellicour, S.; Greenwood, B.  Systematic Review: Impact of Meningococcal Vaccination on Pharyngeal Carriage of Meningococci.   Trop Med Int Health; October 24, 2007. [Epub ahead of print].

  20. Dopp, J. M.; Wiegert, N. A.; Moran, J. J.; Muller, D.; Weber, S.; Hayney, M. S.  Humoral Immune Responses to Influenza Vaccination in Patients With Obstructive Sleep Apnea.   Pharmacotherapy; 27 (11): 1483-1489; November, 2007.

  21. Duval, B.; Gilca, V.; McNeil, S.; Dobson, S.; Money, D.; Gemmill, I. M.; Sauvageau, C.; Lavoie, F.; Ouakki, M.  Vaccination Against Human Papillomavirus: A Baseline Survey of Canadian Clinicians' Knowledge, Attitudes and Beliefs.   Vaccine; 25 (45): 7841-7847; November 7, 2007.

  22. Eckrode, C.; Church, N.; English, W. J., III  Implementation and Evaluation of a Nursing Assessment/Standing Orders-Based Inpatient Pneumococcal Vaccination Program.   Am J Infect Control; 35 (8): 508-515; October, 2007.

  23. Fiks, A. G.; Grundmeier, R. W.; Biggs, L. M.; Localio, A. R.; Alessandrini, E. A.  Impact of Clinical Alerts Within an Electronic Health Record on Routine Childhood Immunization in an Urban Pediatric Population.   Pediatrics; 120 (4): 707-714; October, 2007.

  24. Fowler, G. L.; Weintraub, E.; Kennedy, A.; Luman, E. T.; Shui, I.; Khromava, A.; Kohl, K.; Gust, D. A.  Vaccine Safety Perceptions and Experience With Adverse Events Following Immunization in Uzbekistan.   Public Health; October 23, 2007. [Epub ahead of print].

  25. Gaglia, M. A., Jr.; Cook, R. L.; Kraemer, K. L.; Rothberg, M. B.  Patient Knowledge and Attitudes About Antiviral Medication and Vaccination for Influenza in an Internal Medicine Clinic.   Clin Infect Dis; 45 (9): 1182-1188; November 1, 2007.

  26. Geirsson, R. T.  From the Advent of HPV Vaccination to Modern Old Science.   Acta Obstet Gynecol Scand; 86 (11): 1282-1283; 2007.

  27. Gelinck, L. B.; van der Bijl, A. E.; Beyer, W. E.; Visser, L. G.; Huizinga, T. W.; van Hogezand, R. A.; Rimmelzwaan, G. F.; Kroon, F. P.  The Effect of Anti-Tumor Necrosis Factor Alpha Treatment on the Antibody Response to Influenza Vaccination.   Ann Rheum Dis; October 26, 2007. [Epub ahead of print].

  28. Glenn, G. M.; Flyer, D. C.; Ellingsworth, L. R.; Frech, S. A.; Frerichs, D. M.; Seid, R. C.; Yu, J.  Transcutaneous Immunization With Heat-Labile Enterotoxin: Development of a Needle-Free Vaccine Patch.   Expert Rev Vaccines; 6 (5): 809-819; October, 2007.

  29. Gust, D. A.; Kennedy, A.; Wolfe, S.; Sheedy, K.; Nguyen, C.; Campbell, S.  Developing Tailored Immunization Materials for Concerned Mothers.   Health Educ Res; October 23, 2007. [Epub ahead of print].

  30. Hicks, L. A.; Harrison, L. H.; Flannery, B.; Hadler, J. L.; Schaffner, W.; Craig, A. S.; Jackson, D.; Thomas, A.; Beall, B.; Lynfield, R.; Reingold, A.; Farley, M. M.; Whitney, C. G.  Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States During the Era of Widespread PCV7 Vaccination, 1998-2004.   J Infect Dis; 196 (9): 1346-1354; November 1, 2007.

  31. Hicks, P.; Tarr, G. A.; Hicks, X. P.  Reminder Cards and Immunization Rates Among Latinos and the Rural Poor in Northeast Colorado.   J Am Board Fam Med; 20 (6): 581-586; November, 2007.

  32. Hinman, A. R.  Rubella Vaccination Strategy.   J Pediatr (Rio J); 83 (5): 389-391; September, 2007.

  33. Holm, M. V.; Blank, P. R.; Szucs, T. D.  Developments in Influenza Vaccination Coverage in England, Scotland and Wales Covering Five Consecutive Seasons From 2001 to 2006.   Vaccine; 25 (46): 7931-7938; November 14, 2007.

  34. Hrabak, K. M.; Campbell, J. R.; Tu, S. W.; McClure, R.; Weida, R. T.  Creating Interoperable Guidelines: Requirements of Vocabulary Standards in Immunization Decision Support.   Medinfo; 12 (Pt 2): 930-934; 2007.

  35. Hughes, C.  Coding Flu Shots: Immunize Against Lost Revenue.   Fam Pract Manag; 14 (9): 35-38; October, 2007.

  36. Ibanez-Jimenez, A.; Pairet-Jofre, G.; Prat-Gonzalez, I.; Sanchez-Doblado, M. J.; Tauler-Suner, M.  [Randomized Clinical Trial on the Effectiveness of a Postal Reminder to Increase Tetanus-Diphtheria Vaccination Coverage in the Young Adult Population].   Enferm Clin; 17 (4): 171-176; July, 2007.

  37. Johnstone, J.; Marrie, T. J.; Eurich, D. T.; Majumdar, S. R.  Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia.   Arch Intern Med; 167 (18): 1938-1943; October 8, 2007.

  38. Jordan, R. E.; Hawker, J. I.; Ayres, J. G.; Tunnicliffe, W.; Adab, P.; Olowokure, B.; Kai, J.; McManus, R. J.; Salter, R.; Cheng, K. K.  A Case-Control Study of Elderly Patients With Acute Respiratory Illness: Effect of Influenza Vaccination on Admission to Hospital in Winter 2003-2004.   Vaccine; 25 (46): 7909-7913; November 14, 2007.

  39. Langley, J. M.  Release of the Statement on Influenza for the 2007 2008 Season From the National Advisory Committee on Immunization.   CMAJ; 177 (9): 1025-1026; October 23, 2007.

  40. Lau, J. T.; Kim, J. H.; Choi, K. C.; Tsui, H. Y.; Yang, X.  Changes in Prevalence of Influenza Vaccination and Strength of Association of Factors Predicting Influenza Vaccination Over Time-Results of Two Population-Based Surveys.   Vaccine; October 11, 2007. [Epub ahead of print].

  41. Leyva-Moral, J. M.; Mogeda-Marina, N.; Sierra, Peinado, V; Caixal-Mata, C.; Fort-Garcia, I.; Collado-Sanchez, J.; Munoz-Blasco, Y.; Marti-Jose, N.  [Attitudes Toward Influenza Vaccination in an Urban Population Older Than 60 Years.].   Enferm Clin; 17 (5): 239-245; September, 2007.

  42. Manuel, O.; Humar, A.; Chen, M. H.; Chernenko, S.; Singer, L. G.; Cobos, I.; Kumar, D.  Immunogenicity and Safety of an Intradermal Boosting Strategy for Vaccination Against Influenza in Lung Transplant Recipients.   Am J Transplant; 7 (11): 2567-2572; November, 2007.

  43. Merlin, M.  [Control of Tropical Epidemics by Vaccination Update].   Med Trop (Mars); 67 (4): 351-356; August, 2007.

  44. Monk, B. J.; Herzog, T. J.  The Evolution of Cost-Effective Screening and Prevention of Cervical Carcinoma: Implications of the 2006 Consensus Guidelines and Human Papillomavirus Vaccination.   Am J Obstet Gynecol; 197 (4): 337-339; October, 2007.

  45. Moser, C.; Amacker, M.; Kammer, A. R.; Rasi, S.; Westerfeld, N.; Zurbriggen, R.  Influenza Virosomes As a Combined Vaccine Carrier and Adjuvant System for Prophylactic and Therapeutic Immunizations.   Expert Rev Vaccines; 6 (5): 711-721; October, 2007.

  46. Moulin, A. M.  [How Can Social Sciences Contribute to Vaccination in the Tropics?].   Med Trop (Mars); 67 (4): 335-339; August, 2007.

  47. Murphy, D.; Hull, L.; Horn, O.; Jones, M.; Marteau, T.; Hotopf, M.; Rona, R. J.; Wessely, S.  Anthrax Vaccination in a Military Population Before the War in Iraq: Side Effects and Informed Choice.   Vaccine; 25 (44): 7641-7648; November 1, 2007.

  48. Nokleby, H.  Neurological Adverse Events of Immunization: Experience With an Aluminum Adjuvanted Meningococcal B Outer Membrane Vesicle Vaccine.   Expert Rev Vaccines; 6 (5): 863-869; October, 2007.

  49. O'Brien, K. L.; Millar, E. V.; Zell, E. R.; Bronsdon, M.; Weatherholtz, R.; Reid, R.; Becenti, J.; Kvamme, S.; Whitney, C. G.; Santosham, M.  Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization Among Immunized and Unimmunized Children in a Community-Randomized Trial.   J Infect Dis; 196 (8): 1211-1220; October 15, 2007.

  50. Ogburn, T.; Espey, E. L.; Contreras, V.; Arroyo, P.  Impact of Clinic Interventions on the Rate of Influenza Vaccination in Pregnant Women.   J Reprod Med; 52 (9): 753-756; September, 2007.

  51. Penland, P.  Disparity in Pediatric Vaccinations Calls for Action.   Tenn Med; 100 (10): 11; October, 2007.

  52. Poland, G. A.; Schaffner, W.  Adult Immunization Guidelines: A Patient Safety and Quality-of-Care Issue.   Ann Intern Med; October 18, 2007. [Epub ahead of print].

  53. Pourabbas, B.; Ziyaeyan, M.; Alborzi, A.; Mardaneh, J.  Efficacy of Measles and Rubella Vaccination One Year After the Nationwide Campaign in Shiraz, Iran.   Int J Infect Dis; October 17, 2007. [Epub ahead of print].

  54. Pree, I.; Reisinger, J.; Focke, M.; Vrtala, S.; Pauli, G.; van, Hage M.; Cromwell, O.; Gadermaier, E.; Egger, C.; Reider, N.; Horak, F.; Valenta, R.; Niederberger, V.  Analysis of Epitope-Specific Immune Responses Induced by Vaccination With Structurally Folded and Unfolded Recombinant Bet v 1 Allergen Derivatives in Man.   J Immunol; 179 (8): 5309-5316; October 15, 2007.

  55. Reinert, P.; Dejos, V.; Clyti, N.; Abitbol, V.  [Immunogenicity and Reactogenicity of DTPa-IPV-HBV/Hib and DTPa-IPV/Hib Vaccines Co-Administered With 7-Valent Pneumococcal Conjugate Vaccine As Primary Vaccination and Booster in Healthy Children, According to the French Vaccine Calendar.].   Arch Pediatr; October 24, 2007. [Epub ahead of print].

  56. Rwashana, A. S.; Williams, D. W.  Enhancing Immunization Coverage Through Health Information Systems: a System Dynamics Approach.   Stud Health Technol Inform; 130: 247-256; 2007.

  57. Saliou, P.  [Eradication of Infectious Diseases by Vaccination].   Med Trop (Mars ); 67 (4): 321-327; August, 2007.

  58. Schaffzin, J. K.; Pollock, L.; Schulte, C.; Henry, K.; Dayan, G.; Blog, D.; Smith, P.  Effectiveness of Previous Mumps Vaccination During a Summer Camp Outbreak.   Pediatrics; 120 (4): e862-e868; October, 2007.

  59. Shinall, M. C., Jr.; Plosa, E. J.; Poehling, K. A.  Validity of Parental Report of Influenza Vaccination in Children 6 to 59 Months of Age.   Pediatrics; 120 (4): e783-e787; October, 2007.

  60. Siddiqi, N.; Khan, A.; Nisar, N.; Siddiqi, A. E.  Assessment of EPI (Expanded Program of Immunization) Vaccine Coverage in a Peri-Urban Area.   J Pak Med Assoc; 57 (8): 391-395; August, 2007.

  61. Silfverdal, S. A.; Ehlin, A.; Montgomery, S. M.  Protection Against Clinical Pertussis Induced by Whole-Cell Pertussis Vaccination Is Related to Primo-Immunisation Intervals.   Vaccine; 25 (43): 7510-7515; October 23, 2007.

  62. Spohn, G.; Bachmann, M. F.  Targeting Osteoporosis and Rheumatoid Arthritis by Active Vaccination Against RANKL.    Adv Exp Med Biol; 602: 135-142; 2007.

  63. Stassen, P. M.; Sanders, J. S.; Kallenberg, C. G.; Stegeman, C. A.  Influenza Vaccination Does Not Result in an Increase in Relapses in Patients With ANCA-Associated Vasculitis.   Nephrol Dial Transplant; October 2, 2007. [Epub ahead of print].

  64. Steenhuis, T. J.; van Aalderen, W. M.; Bloksma, N.; Nijkamp, F. P.; van der, Laag J.; van, Loveren H.; Rijkers, G. T.; Kuis, W.; Hoekstra, M. O.  Bacille-Calmette-Guerin Vaccination and the Development of Allergic Disease in Children: a Randomized, Prospective, Single-Blind Study.   Clin Exp Allergy; October 23, 2007. [Epub ahead of print].

  65. Stuve, O.; Eagar, T. N.; Frohman, E. M.; Cravens, P. D.  DNA Plasmid Vaccination for Multiple Sclerosis.   Arch Neurol; 64 (10): 1385-1386; October, 2007.

  66. Sugawara, T.; Ohkusa, Y.; Taya, K.; Oikawa, K.; Haneda, N.; Kikuchi, K.; Kato, F.; Yamaguchi, S.; Yoshikawa, T.; Nakano, T.; Ihara, T.; Tutumi, H.; Asano, Y.; Kamiya, H.; Okabe, N.  [Cost-Effectiveness Analysis of Routine Mumps Immunization in Japan].   Kansenshogaku Zasshi; 81 (5): 555-561; September, 2007.

  67. Swaan, C. M.; van der Sande, M. A.; Speelman, P.; Conyn-van Spaendonck, M. A.; Straus, S. M.; Coutinho, R. A.  [Adverse Events Following Influenza Vaccination: Reaction to Specific Reports and the Necessity of a Central Registration System].   Ned Tijdschr Geneeskd; 151 (39): 2166-2169; September 29, 2007.

  68. Temte, J. L.; Campos-Outcalt, D.  Strengthening Adult and Adolescent Immunization: a Policy Without a Home.   Clin Infect Dis; 45 (10): 1402-1403; November 15, 2007.

  69. Treanor, J. D.  Influenza--the Goal of Control.   N Engl J Med; 357 (14): 1439-1441; October 4, 2007.

  70. Tzeel, A.  Best Practice From a Health Plan Standpoint: the 'Who, How, and When' of Influenza Immunization.   Manag Care; 16 (8 Suppl 8): 10-12; August, 2007.

  71. van Lint, A. L.; Torres-Lopez, E.; Knipe, D. M.  Immunization With a Replication-Defective Herpes Simplex Virus 2 Mutant Reduces Herpes Simplex Virus 1 Infection and Prevents Ocular Disease.    Virology; 368(2): 227-231; October 1, 2007.

  72. Vandenbark, A. A.; Culbertson, N. E.; Bartholomew, R. M.; Huan, J.; Agotsch, M.; Latocha, D.; Yadav, V.; Mass, M.; Whitham, R.; Lovera, J.; Milano, J.; Theofan, G.; Chou, Y. K.; Offner, H.; Bourdette, D. N.  Therapeutic Vaccination With a Trivalent T-Cell Receptor (TCR) Peptide Vaccine Restores Deficient FoxP3 Expression and TCR Recognition in Subjects With Multiple Sclerosis.   Immunology; October 18, 2007. [Epub ahead of print].

  73. Vivancos, R.; Martinez, R.  Performance Assessment of the Ugandan National Programme of Immunization in Masindi: Analysis of Routine Data.   J Trop Pediatr; October 26, 2007. [Epub ahead of print].

  74. Winston, C. A.; Mims, A. D.; Leatherwood, K. A.  Increasing Pneumococcal Vaccination in Managed Care Through Telephone Outreach.   Am J Manag Care; 13 (10): 581-588; October, 2007.

  75. Yalcin, B.; Alli, N.  Pemphigus Vulgaris Following Antirabies Vaccination.   J Dermatol; 34 (10): 734-735; October, 2007.

  76. Yeh, S. H.; Lieberman, J. M.  Update on Adolescent Immunization: Pertussis, Meningococcus, HPV, and the Future.   Cleve Clin J Med; 74 (10): 714-727; October, 2007.

  77. Zhang, W. H.; Zhuang, H.  [Acceleration the Establishment of the Strategies for Heaptitis A Immunization].   Zhonghua Liu Xing Bing Xue Za Zhi; 28 (6): 521-522; June, 2007.

  78. Zhou, B.; Zhong, N.; Guan, Y.  Treatment With Convalescent Plasma for Influenza A (H5N1) Infection.   N Engl J Med; 357 (14): 1450-1451; October 4, 2007.